Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Controlled Release

• Publication date

  2006-02-21

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.JCONREL.2005.10.010PMID 16360956
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Meningococcal Vaccines

  2012cited by this paper
• Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial.

  2004cited by this paper
• Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial.

  2004cited by this paper
• Anionic microparticles are a potent delivery system for recombinant antigens from Neisseria meningitidis serotype B.

  2004cited by this paper
• Adsorption of a Novel Recombinant Glycoprotein from HIV (Env gp120dV2 SF162) to Anionic PLG Microparticles Retains the Structural Integrity of the Protein, Whereas Encapsulation in PLG Microparticles Does Not

  2004cited by this paper
• Purification, Characterization, and Immunogenicity of a Soluble Trimeric Envelope Protein Containing a Partial Deletion of the V2 Loop Derived from SF162, an R5-Tropic Human Immunodeficiency Virus Type 1 Isolate

  2003cited by this paper
• Microparticles as vaccine adjuvants and delivery systems

  2003cited by this paper
• Induction of Broad and Potent Anti-Human Immunodeficiency Virus Immune Responses in Rhesus Macaques by Priming with a DNA Vaccine and Boosting with Protein-Adsorbed Polylactide Coglycolide Microparticles

  2003cited by this paper
• Uptake of poly(D,L-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo.

  2002cited by this paper
• Adjuvants of Immunity

  2002cited by this paper
• Meningococcal disease: treatment and prevention

  2002cited by this paper
• Cationic Microparticles Are an Effective Delivery System for Immune Stimulatory CpG DNA

  2001cited by this paper
• Toll-like receptors and innate immunity

  2001cited by this paper
• Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

  2000influential reference
• Differential Expression and Regulation of Toll-Like Receptors (TLR) in Human Leukocytes: Selective Expression of TLR3 in Dendritic Cells1

  2000cited by this paper
• Novel anionic microparticles are a potent adjuvant for the induction of cytotoxic T lymphocytes against recombinant p55 gag from HIV-1.

  2000cited by this paper
• Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administration.

  2000cited by this paper
• Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide.

  2000cited by this paper
• CD14 Employs Hydrophilic Regions to “Capture” Lipopolysaccharides

  2000cited by this paper
• Monophosphoryl lipid A (MPL) formulations for the next generation of vaccines.

  1999cited by this paper
• The adjuvant combination monophosphoryl lipid A and QS21 switches T cell responses induced with a soluble recombinant HIV protein from Th2 to Th1.

  1999cited by this paper
• Signaling events induced by lipopolysaccharide-activated toll-like receptor 2.

  1999cited by this paper
• CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen.

  1998cited by this paper
• Improving protein therapeutics with sustained-release formulations

  1998cited by this paper
• An ancient system of host defense.

  1998cited by this paper
• Human Toll-like Receptor 2 Confers Responsiveness to Bacterial Lipopolysaccharide

  1998cited by this paper
• Lipopolysaccharide and monophosphoryl lipid A differentially regulate interleukin-12, gamma interferon, and interleukin-10 mRNA production in murine macrophages

  1997cited by this paper
• Biodegradable microspheres in drug delivery.

  1995cited by this paper
• Vaccine Design

  1995cited by this paper
• Adjuvant properties of aluminum and calcium compounds.

  1995cited by this paper
• Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells.

  1995cited by this paper
• Monophosphoryl Lipid A as an Adjuvant

  1995cited by this paper
• Adjuvants for human vaccines--current status, problems and future prospects.

  1995cited by this paper
• Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles.

  1994cited by this paper
• Molecular adjuvants and immunomodulators: new approaches to immunization

  1994cited by this paper
• Macrophage phagocytosis of biodegradable microspheres composed of L-lactic acid/glycolic acid homo- and copolymers.

  1988cited by this paper
• Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production.

  1987cited by this paper

• Advancements in saponin-based vaccine adjuvants

  2025cites this paper
• Sustained release system from PLGA particles co-encapsulated with inactivated influenza virus with natural killer T cell agonist α-galactosylceramide.

  2024cites this paper
• Dissolving Microneedles Loaded with Nanoparticle Formulation of Respiratory Syncytial Virus Fusion Protein Virus-like Particles (F-VLPs) Elicits Cellular and Humoral Immune Responses

  2023cites this paper
• Laser-assisted intradermal delivery of a microparticle vaccine for respiratory syncytial virus induces a robust immune response.

  2023cites this paper
• PLGA Particles in Immunotherapy

  2023cites this paper
• Synthesis and characterization of lipopolysaccharide (LPS) anchored polystyrene microparticles as a synthetic model system for attachment studies.

  2023cites this paper
• Chitosan-Based Nanomaterial as Immune Adjuvant and Delivery Carrier for Vaccines

  2022cites this paper
• Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccine

  2022cites this paper
• Six decades of infectious bursal disease in poultry: The journey so far and challenges ahead

  2021cites this paper
• Co-delivery of PLGA nanoparticles loaded with rSAG1 antigen and TLR ligands: An efficient vaccine against chronic toxoplasmosis.

  2021cites this paper
• Nanocarrier vaccines for SARS-CoV-2

  2021cites this paper
• 3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope–specific plasma cells and humoral immunity in nonhuman primates

  2020cites this paper
• Bicistronic DNA vaccine macromolecule complexed with poly lactic-co-glycolic acid-chitosan nanoparticles enhanced the mucosal immunity of Labeo rohita against Edwardsiella tarda infection.

  2020cites this paper
• In-vitro and in-vivo comparison of rSAG1-loaded PLGA prepared by encapsulation and adsorption methods as an efficient vaccine against Toxoplasma gondii”

  2020cites this paper
• Biocompatibility, biodegradation and biomedical applications of poly(lactic acid)/poly(lactic-co-glycolic acid) micro and nanoparticles

  2019cites this paper
• Particulate carrier systems as adjuvants for cancer vaccines.

  2019cites this paper
• Pentaerythritol-based lipid A bolsters the antitumor efficacy of a polyanhydride particle-based cancer vaccine.

  2019cites this paper
• Self-assembled amphiphilic copolymers as dual delivery system for immunotherapy.

  2019cites this paper
• Stimuli-responsive poly(phenyl acetylene) microparticles with tunable chirality

  2019cites this paper
• Polyester as Antigen Carrier toward Particulate Vaccines.

  2019cites this paper
• Harnessing Dendritic Cells for Poly (D,L-lactide-co-glycolide) Microspheres (PLGA MS)—Mediated Anti-tumor Therapy

  2019cites this paper
• Recent advances of PLGA micro/nanoparticles for the delivery of biomacromolecular therapeutics.

  2018cites this paper
• Poly(lactic-co-glycolic acid): The most ardent and flexible candidate in biomedicine!

  2018cites this paper
• PLGA-encapsulation of the Pseudomonas aeruginosa PopB vaccine antigen improves Th17 responses and confers protection against experimental acute pneumonia.

  2018cites this paper
• Induction of Immunity against Marek’s Disease using Toll-Like Receptor Ligands

  2018cites this paper
• Investigation of tunable acetalated dextran microparticle platform to optimize M2e‐based influenza vaccine efficacy

  2018cites this paper
• Tunable degradation of acetalated dextran microparticles enables controlled vaccine adjuvant and antigen delivery to modulate adaptive immune responses

  2018cites this paper
• Endolysosomal-Escape Nanovaccines through Adjuvant-Induced Tumor Antigen Assembly for Enhanced Effector CD8+ T Cell Activation.

  2018cites this paper
• Development of Adjuvanted Solid Fat Nanoemulsions for Pulmonary Hepatitis B Vaccination.

  2018cites this paper
• 2-Dimensional colloidal micropatterning of cholesteric liquid crystal microcapsules for temperature-responsive color displays

  2018cites this paper
• Characterization of innate responses induced by in ovo administration of encapsulated and free forms of ligands of Toll-like receptor 4 and 21 in chicken embryos.

  2017cites this paper
• A Poly(Lactic-co-Glycolic) Acid Nanovaccine Based on Chimeric Peptides from Different Leishmania infantum Proteins Induces Dendritic Cells Maturation and Promotes Peptide-Specific IFNγ-Producing CD8+ T Cells Essential for the Protection against Experimental Visceral Leishmaniasis

  2017cites this paper
• Overview of Vaccine Adjuvants: Introduction, History, and Current Status.

  2017cites this paper
• Characterization of Innate Responses Induced by PLGA Encapsulated- and Soluble TLR Ligands In Vitro and In Vivo in Chickens

  2017cites this paper
• Polymeric Particles as Vaccine Delivery Systems

  2017cites this paper
• infectious bursal disease virus in poultry: current status and future prospects

  2016cites this paper
• Effect of Experimental Parameters on Alginate/Chitosan Microparticles for BCG Encapsulation

  2016cites this paper
• Acetalated Dextran Microparticulate Vaccine Formulated via Coaxial Electrospray Preserves Toxin Neutralization and Enhances Murine Survival Following Inhalational Bacillus Anthracis Exposure

  2016cites this paper
• Synergistic effect of rSAG1 and rGRA2 antigens formulated in PLGA microspheres in eliciting immune protection against Toxoplasama gondii.

  2016cites this paper
• Peptide/protein vaccine delivery system based on PLGA particles

  2016cites this paper
• PLGA particulate delivery systems for subunit vaccines : Linking particle properties to immunogenicity

  2016cites this paper
• Anti-tumor immunity induced by a novel nanoparticulate vaccine : a mechanistic approach

  2016cites this paper
• Cubosome nanoparticles potentiate immune properties of immunostimulants

  2016cites this paper
• The preparation and characterization of PLG nanoparticles with an entrapped synthetic TLR7 agonist and their preclinical evaluation as adjuvant for an adsorbed DTaP vaccine.

  2016cites this paper
• Infectious bursal disease virus in poultry: current status and future prospects

  2016cites this paper
• Novel particulate BCG-loaded delivery system for mucosal immunization against tuberculosis

  2016cites this paper
• PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity

  2016cites this paper
• Translational Peptide-associated Nanosystems: Promising Role as Cancer Vaccines.

  2015cites this paper
• On the synthesis of mucus permeating nanocarriers.

  2015cites this paper
• New generation adjuvants--from empiricism to rational design.

  2015cites this paper
• Photosensitizer and Light Pave the Way for Cytosolic Targeting and Generation of Cytosolic CD8 T Cells Using PLGA Vaccine Particles

  2015cites this paper
• PLGA-based particulate vaccine delivery systems for immunotherapy of cancer

  2015influential citation
• Development of nanosystems for HIV vaccine delivery

  2014influential citation
• Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation.

  2014cites this paper
• Cancer immunotherapy: nanodelivery approaches for immune cell targeting and tracking

  2014cites this paper
• Preparation and In Vitro Evaluation of Imiquimod Loaded Polylactide-based Micelles as Potential Vaccine Adjuvants

  2014cites this paper
• Physicochemical and functional characterization of vaccine antigens and adjuvants

  2014cites this paper
• Recent progress in adjuvant discovery for peptide-based subunit vaccines

  2014cites this paper
• Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery.

  2014cites this paper
• Designing and building the next generation of improved vaccine adjuvants.

  2014cites this paper
• Enzyme-Functionalized PLGA Nanoparticles with Enhanced Mucus Permeation Rate

  2014cites this paper
• Nanoparticle delivery of donor antigens for transplant tolerance in allogeneic islet transplantation.

  2014cites this paper
• Encapsulation of Nod1 and Nod2 receptor ligands into poly(lactic acid) nanoparticles potentiates their immune properties.

  2013cites this paper
• Vaccine delivery carriers: insights and future perspectives.

  2013cites this paper
• Transcutaneous immunization using lipid colloidal systems and microneedles

  2013cites this paper
• Engineering biomaterial-associated complement activation to improve vaccine efficacy.

  2013cites this paper
• Adjuvant Strategies for Vaccines: The Use of Adjuvants within the Cancer Vaccine Setting

  2013cites this paper
• Immunobioengineering Approaches Towards Combinatorial Delivery of Immune-Modulators and Antigens

  2013cites this paper
• Alginate-coated chitosan nanogel capacity to modulate the effect of TLR ligands on blood dendritic cells.

  2013cites this paper
• Malaria Vaccine Adjuvants: Latest Update and Challenges in Preclinical and Clinical Research

  2013cites this paper
• Delivery of host cell-directed therapeutics for intracellular pathogen clearance

  2013cites this paper
• Vaccine adjuvant formulations: a pharmaceutical perspective.

  2013cites this paper
• Engineering synthetic vaccines using cues from natural immunity.

  2013cites this paper
• Robust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccine.

  2012cites this paper
• Modulation of Dendritic Cells by Lipid Grafted Polyelectrolyte Microcapsules

  2012cites this paper
• Nanoimmunotherapy: application of nanotechnology for sustained and targeted delivery of antigens to dendritic cells.

  2012cites this paper
• Engineering Nano‐ and Microparticles to Tune Immunity

  2012cites this paper
• Antigen-Displaying Lipid-Enveloped PLGA Nanoparticles as Delivery Agents for a Plasmodium vivax Malaria Vaccine

  2012cites this paper
• Dendritic cell activation and T cell priming with adjuvant- and antigen-loaded oxidation-sensitive polymersomes.

  2012cites this paper
• Recent advances in microparticle and nanoparticle delivery vehicles for mucosal vaccination.

  2012cites this paper
• Adjuvants: from serendipity to rational discovery.

  2012cites this paper
• “Wrapped Up” Vaccines in the Context of HIV-1 Immunotherapy

  2012cites this paper
• Injectable PLGA Systems for Delivery of Vaccine Antigens

  2012cites this paper
• Part I: targeted particles for cancer immunotherapy.

  2011cites this paper
• Nanocarrier Aided Nasal Vaccination: An Experimental and Computational Approach

  2011cites this paper
• Development of novel vaccine formulations against pertussis for early life vaccination in the presence of maternal antibodies

  2011cites this paper
• Potentiating Effects of MPL on DSPC Bearing Cationic Liposomes Promote Recombinant GP63 Vaccine Efficacy: High Immunogenicity and Protection

  2011cites this paper
• In vivo evidence of oral vaccination with PLGA nanoparticles containing the immunostimulant monophosphoryl lipid A.

  2011cites this paper
• Designing polymeric particles for antigen delivery.

  2011cites this paper
• 4.419 – Vaccine and Immunotherapy Delivery

  2011cites this paper
• Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations.

  2011cites this paper
• The long-term potential of biodegradable poly(lactideco-glycolide) microparticles as the next-generation vaccine adjuvant

  2011cites this paper
• Synthetic pathogens for integrated biophysical and genetic dissection of antigen cross-presentation

  2010cites this paper
• Micro/nanoparticle adjuvants: preparation and formulation with antigens.

  2010cites this paper
• Programming the magnitude and persistence of antibody responses with innate immunity

  2010cites this paper
• Advances in the design and delivery of peptide subunit vaccines with a focus on Toll-like receptor agonists

  2010cites this paper
• Enhancing the therapeutic efficacy of CpG oligonucleotides using biodegradable microparticles.

  2009cites this paper
• Strategies to link innate and adaptive immunity when designing vaccine adjuvants.

  2009cites this paper
• Vaccine adjuvants: current challenges and future approaches.

  2009cites this paper
• MF59 Emulsion Is an Effective Delivery System for a Synthetic TLR4 Agonist (E6020)

  2009cites this paper